Patents by Inventor Kathryn Erickson

Kathryn Erickson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS RELATING TO OLANZAPINE PHARMACOGENETICS
    Publication number: 20110223597
    Abstract: There is significant variability in subject clearance, half-life and side-effects from treatment with olanzapine (OLZ) in subjects. Methods for aiding in determining therapeutic efficacy of olanzapine in a subject are provided according to embodiments of the present invention which include identifying in a subject sample whether UDP-glucuronosyltransferase 2B10 (UGT2B10) and/or UDP-glucuronosyltransferase 1A4 (UGT1A4) is “wild-type” or a variant associated with altered glucuronidation of an olanzapine metabolite compared to wild-type.
    Type: Application
    Filed: March 10, 2011
    Publication date: September 15, 2011
    Applicant: The Penn State Research Foundation
    Inventors: Philip Lazarus, Kathryn Erickson